Reassessment of the indications for ribavirin therapy in respiratory syncytial virus infections

N. A. Halsey, P. J. Chesney, M. A. Gerber, D. S. Gromisch, S. Kohl, S. M. Marcy, M. I. Marks, Dennis L Murray, J. C. Overall, L. K. Pickering, R. J. Whitley, R. Yogev, G. Peter, R. L. Berkelman, M. C. Hardgree, R. F. Jacobs, N. E. MacDonald, W. A. Orenstein, N. R. Rabinovich

Research output: Contribution to journalReview article

164 Citations (Scopus)

Abstract

The purpose of this statement is to inform practitioners about new information concerning lack of demonstrated clinical effectiveness of ribavirin in the treatment of infants with respiratory syncytial virus (RSV) disease. The intent of the new recommendation is to allow practitioners to decide whether ribavirin therapy is appropriate or not by taking into account the particular clinical situation and their own preferences. More definitive answers to the questions of ribavirin efficacy and effectiveness will require multi-institutional, prospective, randomized clinical trials. Recommendations may be modified as new information becomes available.

Original languageEnglish (US)
Pages (from-to)137-140
Number of pages4
JournalPediatrics
Volume97
Issue number1
StatePublished - Jan 1 1996

Fingerprint

Respiratory Syncytial Virus Infections
Ribavirin
Respiratory Syncytial Viruses
Virus Diseases
Therapeutics
Randomized Controlled Trials

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health

Cite this

Halsey, N. A., Chesney, P. J., Gerber, M. A., Gromisch, D. S., Kohl, S., Marcy, S. M., ... Rabinovich, N. R. (1996). Reassessment of the indications for ribavirin therapy in respiratory syncytial virus infections. Pediatrics, 97(1), 137-140.

Reassessment of the indications for ribavirin therapy in respiratory syncytial virus infections. / Halsey, N. A.; Chesney, P. J.; Gerber, M. A.; Gromisch, D. S.; Kohl, S.; Marcy, S. M.; Marks, M. I.; Murray, Dennis L; Overall, J. C.; Pickering, L. K.; Whitley, R. J.; Yogev, R.; Peter, G.; Berkelman, R. L.; Hardgree, M. C.; Jacobs, R. F.; MacDonald, N. E.; Orenstein, W. A.; Rabinovich, N. R.

In: Pediatrics, Vol. 97, No. 1, 01.01.1996, p. 137-140.

Research output: Contribution to journalReview article

Halsey, NA, Chesney, PJ, Gerber, MA, Gromisch, DS, Kohl, S, Marcy, SM, Marks, MI, Murray, DL, Overall, JC, Pickering, LK, Whitley, RJ, Yogev, R, Peter, G, Berkelman, RL, Hardgree, MC, Jacobs, RF, MacDonald, NE, Orenstein, WA & Rabinovich, NR 1996, 'Reassessment of the indications for ribavirin therapy in respiratory syncytial virus infections', Pediatrics, vol. 97, no. 1, pp. 137-140.
Halsey NA, Chesney PJ, Gerber MA, Gromisch DS, Kohl S, Marcy SM et al. Reassessment of the indications for ribavirin therapy in respiratory syncytial virus infections. Pediatrics. 1996 Jan 1;97(1):137-140.
Halsey, N. A. ; Chesney, P. J. ; Gerber, M. A. ; Gromisch, D. S. ; Kohl, S. ; Marcy, S. M. ; Marks, M. I. ; Murray, Dennis L ; Overall, J. C. ; Pickering, L. K. ; Whitley, R. J. ; Yogev, R. ; Peter, G. ; Berkelman, R. L. ; Hardgree, M. C. ; Jacobs, R. F. ; MacDonald, N. E. ; Orenstein, W. A. ; Rabinovich, N. R. / Reassessment of the indications for ribavirin therapy in respiratory syncytial virus infections. In: Pediatrics. 1996 ; Vol. 97, No. 1. pp. 137-140.
@article{af5ae43c265c45eb932cb13178869e60,
title = "Reassessment of the indications for ribavirin therapy in respiratory syncytial virus infections",
abstract = "The purpose of this statement is to inform practitioners about new information concerning lack of demonstrated clinical effectiveness of ribavirin in the treatment of infants with respiratory syncytial virus (RSV) disease. The intent of the new recommendation is to allow practitioners to decide whether ribavirin therapy is appropriate or not by taking into account the particular clinical situation and their own preferences. More definitive answers to the questions of ribavirin efficacy and effectiveness will require multi-institutional, prospective, randomized clinical trials. Recommendations may be modified as new information becomes available.",
author = "Halsey, {N. A.} and Chesney, {P. J.} and Gerber, {M. A.} and Gromisch, {D. S.} and S. Kohl and Marcy, {S. M.} and Marks, {M. I.} and Murray, {Dennis L} and Overall, {J. C.} and Pickering, {L. K.} and Whitley, {R. J.} and R. Yogev and G. Peter and Berkelman, {R. L.} and Hardgree, {M. C.} and Jacobs, {R. F.} and MacDonald, {N. E.} and Orenstein, {W. A.} and Rabinovich, {N. R.}",
year = "1996",
month = "1",
day = "1",
language = "English (US)",
volume = "97",
pages = "137--140",
journal = "Pediatrics",
issn = "0031-4005",
publisher = "American Academy of Pediatrics",
number = "1",

}

TY - JOUR

T1 - Reassessment of the indications for ribavirin therapy in respiratory syncytial virus infections

AU - Halsey, N. A.

AU - Chesney, P. J.

AU - Gerber, M. A.

AU - Gromisch, D. S.

AU - Kohl, S.

AU - Marcy, S. M.

AU - Marks, M. I.

AU - Murray, Dennis L

AU - Overall, J. C.

AU - Pickering, L. K.

AU - Whitley, R. J.

AU - Yogev, R.

AU - Peter, G.

AU - Berkelman, R. L.

AU - Hardgree, M. C.

AU - Jacobs, R. F.

AU - MacDonald, N. E.

AU - Orenstein, W. A.

AU - Rabinovich, N. R.

PY - 1996/1/1

Y1 - 1996/1/1

N2 - The purpose of this statement is to inform practitioners about new information concerning lack of demonstrated clinical effectiveness of ribavirin in the treatment of infants with respiratory syncytial virus (RSV) disease. The intent of the new recommendation is to allow practitioners to decide whether ribavirin therapy is appropriate or not by taking into account the particular clinical situation and their own preferences. More definitive answers to the questions of ribavirin efficacy and effectiveness will require multi-institutional, prospective, randomized clinical trials. Recommendations may be modified as new information becomes available.

AB - The purpose of this statement is to inform practitioners about new information concerning lack of demonstrated clinical effectiveness of ribavirin in the treatment of infants with respiratory syncytial virus (RSV) disease. The intent of the new recommendation is to allow practitioners to decide whether ribavirin therapy is appropriate or not by taking into account the particular clinical situation and their own preferences. More definitive answers to the questions of ribavirin efficacy and effectiveness will require multi-institutional, prospective, randomized clinical trials. Recommendations may be modified as new information becomes available.

UR - http://www.scopus.com/inward/record.url?scp=2442671303&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=2442671303&partnerID=8YFLogxK

M3 - Review article

VL - 97

SP - 137

EP - 140

JO - Pediatrics

JF - Pediatrics

SN - 0031-4005

IS - 1

ER -